"The only thing revive has going for is its lower float, but that may not last long because they need to pay the their high salaries and bonuses."
Sorry chap but revive isnt going to start issuing shares like theres no tomorrow as relief does, ie 4,416,334,617 @ 10/31/2022 vs ~360M @ 01/01/2023.....
Well, thus far revive has been exhibiting the same downward trajectory as relief.
EDIT: Of course if the fda rejects an eua it will plunge even more. The point is they havent rejected the ep change nor has revive even submitted an eua request so the foolish comparisons to reliefs pps nosedive at this time are just that......FOOLISH!!!